Pfizer is constantly aiming to deliver on our purpose – Breakthroughs That Change Patients’ Lives. As part of the Commercial Strategy and Innovation group within the Business Innovation (BI) organization, Pfizer’s Competitive Intelligence (CI) Center of Excellence is uniquely positioned to support this goal.

The CI Team, with colleagues at Pfizer’s New York Headquarters and a global Research and Analysis team, includes subject-matter experts from a diverse set of backgrounds and experiences. Together we collaborate to provide Pfizer leadership with competitive assessments curated and crystalized into actionable insights that enable industry-leading, enterprise-focused decision-making for early- and late-stage pipeline assets across Pfizer’s Business Innovation, R&D (ORD and PRD), Digital, and commercial organizations.

The Industry Insights Senior Associate with a focus on, but not limited to, Pfizer’s Oncology pipeline, will work in close collaboration with multiple cross-functional teams and senior leaders to represent and align on a unified view of the external micro and macro business environment within or ahead of internal discussions, business planning, key processes, and decision-making forums.

ROLE SUMMARY

In partnership with US, EU and China-based team members, the Industry Insights Senior Associate, will evaluate the pharmaceutical micro and macro business environment to develop strategic insights and analyses for key internal discussions, business planning and decision-making forums for pipeline, business development (BD), and category initiatives.

The Senior Associate will perform secondary research, leveraging multiple sources of publicly-disclosed information (databases, regulatory filings, company disclosures, industry reports, analyst commentary, etc.) to support the identification and communication of industry, company, therapeutic area and candidate-level updates across the external environment, create clinical data and trial comparisons for known external pipeline candidates, forecast external candidate milestones and timelines, and prepare asset and company deep dives.

This individual will partner with local and global teams across Pfizer’s commercial development and business development functions and interact with representatives from other cross-functional partners to help define company, category and candidate specific strategies.

ROLE RESPONSIBILITIES

• Operate independently under guidance from the External Insights Guide and the Category Directors
• Execute internal secondary research, including monitoring, analysis and reporting of the external preclinical, clinical and commercial landscape, as well as clinical data and timelines in areas aligned to Pfizer’s research, development and commercial areas of focus
• Monitor industry activities, pipeline and product progression, financial forecasts, and BD projects, and provide strategic insights to senior leaders across Pfizer
• Act as a thought partner with commercial development, BD and R&D teams by providing analyses and insights that inform program development and investment decisions
• Maintain and enhance the in-house knowledge management system, ensuring timely updates and accurate tagging of research outputs
• Mentor junior team members, providing guidance on research methodologies and best practices

BASIC QUALIFICATIONS

• Minimum of three years of experience working in strategy, consulting or related roles in healthcare/pharma
• Advanced life science degree preferred (Minimum MSc) with a preference for advanced degree holders who have a focus in business, medicine, or science

• Interest and/or expertise in therapeutic and disease areas aligned to Pfizer’s research and development programs

• Broad knowledge of the pharmaceutical industry, global healthcare environment as well as multinational and local pharmaceutical companies
• Service-oriented, highly collaborative, self-motivated, curious, and results-oriented

#LI-PFE

Pfizer is an equal opportunity employer and complies with all applicable equal employment opportunity legislation in each jurisdiction in which it operates.